Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Superior Prima Sukses Tbk. (BLES) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Superior Prima Sukses Tbk.
UBC Medical Indonesia Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Superior Prima Sukses Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Superior Prima Sukses Tbk. trades at Rp140 (market cap 1.25T, 591.3K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: Superior Prima Sukses Tbk. is far larger — about 2.1× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (1.44M versus 591.3K). Which is the better fit depends on your goals.

BLESLABS
Market Cap
1.25T584.6B
Volume
591.3K1.44M
Lot
5.91K14.4K
Turnover
83.24M209.72M
Average Price
140.77145.64
Value
83.24M209.72M
Indicative Equilibrium Price
140146
Indicative Equilibrium Volume
408753

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BLES
View details
LABS
View details

About Superior Prima Sukses Tbk.

PT Superior Prima Sukses Tbk (the Company) was established based on Notarial Deed of Sriwati, S.H., M.Hum., No. 8 dated November 3, 2011. The Company started its operations in April 2013. PT Global Base Universal is the ultimate parent entity of the Company.

Read more on BLES

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS